What is the main corporate governance change discussed in this filing?

The main change is the shareholder approval to eliminate the company's classified board structure. This means that all directors will eventually be elected annually, rather than in staggered terms, which is a shift towards modern corporate governance best practices. This change is subject to the company's contractual obligations with the Blue Cross and Blue Shield Association (BCBSA).

When will the elimination of the classified board structure become fully effective?

The elimination of the classified board structure will become fully effective when permitted by the company's contractual obligations with the Blue Cross and Blue Shield Association (BCBSA). While the amendments were approved and filed on May 15, 2019, the practical implementation of annual director elections is dependent on those BCBSA agreements.

How did shareholders vote on key proposals, such as director elections and executive compensation?

Shareholders overwhelmingly elected the nominated directors to three-year terms and provided advisory approval for the company's executive compensation. The ratification of Ernst & Young LLP as the independent auditor and the amendments to eliminate the classified board structure also received substantial shareholder support, indicating confidence in the company's governance and financial oversight.

What is the significance of the shareholder proposal to elect each director annually?

The approval of this shareholder proposal further signals the company's move towards enhanced director accountability. It aligns with the broader initiative to declassify the board, ensuring that shareholders have the opportunity to vote on the election of all directors on an annual basis, provided it does not conflict with existing contractual obligations.

ELV 8-K: Shareholder Matters & Corporate Changes

Summary

This 8-K filing by Elevance Health, Inc. (formerly Anthem, Inc.) primarily reports on key corporate governance changes approved by shareholders at their Annual Meeting on May 15, 2019. The most significant update is the approval of amendments to the company's Articles of Incorporation and Bylaws to eliminate the classified board structure, a move that will be fully effective when permitted by its contractual obligations with the Blue Cross and Blue Shield Association (BCBSA). This change aims to align with best practices in corporate governance, allowing for annual election of all directors. Additionally, the filing details the results of various shareholder votes, including the election of directors, ratification of Ernst & Young LLP as the independent auditor, advisory approval of executive compensation, and a shareholder proposal to elect each director annually when feasible. The overwhelming support for these proposals, particularly the elimination of the classified board and the auditor ratification, signals strong shareholder confidence in the company's management and governance direction.

Key Highlights

1Shareholders approved amendments to the Articles of Incorporation and Bylaws to eliminate the classified board structure, contingent on BCBSA contractual obligations.
2The company's Board of Directors was also amended to reflect this change towards a declassified board structure.
3All nominated directors were elected to serve three-year terms, indicating shareholder confidence in current leadership.
4Ernst & Young LLP was ratified as the independent registered public accounting firm for 2019 with strong shareholder support.
5Shareholders provided advisory approval for the company's executive compensation practices.
6A shareholder proposal to elect each director annually was approved, reinforcing the move towards greater director accountability.
7The amendments to the Articles of Incorporation were officially filed with the Indiana Secretary of State, making them effective as of May 15, 2019.

Elevance Health, Inc. 8-K Report, Bylaw Amendment (May 15, 2019)

Summary

Key Highlights

Frequently Asked Questions